Galcanezumab Completed Phase 3 Trials for Episodic Cluster Headache Treatment

IndicationsStatusPurposePhase
CompletedTreatment3
clinicaltrials.gov IdentifierTitleDrugs
NCT02397473A Study Of Galcanezumab In Participants With Episodic Cluster Headache